Advanced Search
Contact | Corporate | Help

Daily news email for April 17, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

 b3c newswire
Labor L+S AG and SYMBIOSIS Form Exclusive Business Alliance

Better Prevention of Transmission and Lesion Development of Genital Herpes Predicted for ...

ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

Human Cell Technology Company Medicyte Awarded ISO 9001 Certification

Genentech and Pfizer Share CDx Success Insights at the 4th Molecular Diagnostics for Cancer ...

 BioSpace
China Cord Blood Corporation Announces $65 Million Investment from Kohlberg Kravis Roberts & Co. L.P.

Pharmaceutical Education and Research Institute (PERI): Biopharma Injected $49.5 Billion in R&D Last Year

Hyperion Therapeutics Files for $58 Million US IPO

Sanofi (France) CEO: Hub's Life Sciences Lead at Risk, Calls for Alliances to Solve Scientic Problems

Left Hand Right Hand, Premature Babies Make the Link, Centre National de la Recherche Scientifique Study

BioSpace - Breaking News
Pluristem Therapeutics Receives U.S. FDA Clearance for Phase II Clinical Trial in Intermittent Claudication

Mesoblast Limited Release: Intervertebral Disc Repair Phase 2 Trial Update

New Phase 2 Data From Brain Cancer Study With Agenus (Formerly known as Antigenics Inc. - New York)' Prophage Vaccine (HSPPC-96) Presented at Plenary Session of

Octagon Research Solutions, Inc. Discusses Regulatory Information Management Best Practices in Europe

Q-Med AB Discontinues the Breast Indication for Macrolane

Biotech News - Business Wire
Exactech Schedules First Quarter 2012 Earnings Release and Conference Call

Abstract Published in Canadian Journal of Surgery Reports Key Preliminary Findings of Major Prospective Study of the KCI ABThera Open Abdomen Negative Pressure Therapy System

Un Resumen Publicado en el Canadian Journal of Surgery Informa sobre Hallazgos Preliminares Clave del Principal Estudio Prospectivo del Sistema KCI ABThera de Terapia de Presión Negativa para Abdomen Abierto

Un résumé publié dans le Canadian Journal of Surgery présente les conclusions préliminaires clés d'une étude prospective majeure du système de thérapie par pression négative pour abdomen ouvert KCI ABThera

Dr. Robert Melamede Scheduled to Speak at the Patients Out of Time 7th National Clinical Conference on Cannabis Therapeutics April 26-28th at Loews Ventana Resort, Tucson, Arizona and is Available for Viewing on Pay Per View

 Biotech News - PR Newswire
Amsterdam Molecular Therapeutics herbevestigt het tijdschema van de vereffening

GBCHealth Elects BD Leader Gary Cohen to Board of Directors

MD&M East 2012 to Feature FDA and Medical Technology Development Leaders

Global Surgical Devices Market Growth Driven by Improving Standards of Living and Longer Life Expectancies, Research Shows

MedNet Solutions to Demonstrate Its Innovative Suite of eClinical Solutions at the 2012 Bio-IT World Conference & Expo
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

 Burrill Report
Amgen to Buy KAI Pharmaceuticals

J&J Fined $1.1 Billion For Deceptive Marketing

Takeda Acquires URL Pharma in $800 Million Deal

Drug Shortages and the Role of the Middle Man

Berwick Says Billions Can Be Saved through Cutting Waste

 CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
Clinical Trials - Business Wire
Watermark Medical Achieves 100,000 Patient Study Milestone

St. Jude Medical Announces First Implant in Clinical Trial for Accent MRI Pacemaker and Tendril MRI Lead System

Pathway Genomics Adds World-Renowned Obesity and Nutrition Experts to Scientific Advisory Board

BioClinica Partners with Paragon Solutions to Create Clinical Architecture

Data from FzioMed's Oxiplex® U.S. Pivotal Clinical Study Published in Spine

 Clinical Trials - PR Newswire
PRA Expert to Speak at Drug Safety Conference

Pill Reduced Number of MS Lesions in Phase II Trial

New Method May Help Detect Marker for Alzheimer's Disease Earlier

PhRMA Statement Regarding Research Partnerships and Clinical Trials

Montefiore Study Reveals High Rate of Anal Cancer in HIV-positive Women

 CNN Top Stories
Sharpton clout growing with AG visit

UK arrests alleged terror fundraiser

GSA whistle-blower: 'I share your anger'

Will U.N. mission affect Syria endgame

140 poisoned at girls school
Contract Pharma
Catalent, Nascent in Antibody Development Pact

AMRI, Biota in Development Deal

Theorem Names Development SVP

West Adds NovaPure Components

AZ, Conformetrix in Preclinical Pact

 FDA Drugs- What's New
FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

FDA Drug Safety Communication: Revised recommendations for Celexa (citalopram hydrobromide) related to a potential risk of abnormal heart rhythms with high doses

 FDA News - Business Wire
BIO Submits Comments on FDA Draft Guidances on Biosimilars

BioClinica to Release First Quarter 2012 Financial Results on May 9, 2012

IVAX Diagnostics, Inc. Reports Fourth Quarter and Full Year 2011 Financial Results

ArQule Announces Completion of Common Stock Offering with Full Exercise of Option to Purchase Additional Shares

Drug Product Lifecycle Management Requires Multi-Pronged Strategy, Finds Cutting Edge Information
FDA Press Releases
Application

CFP Online Application

Harry and David Issues Allergy Alert on Undeclared Peanuts in Harry & David Premium Kansas City Style Barbeque Almonds

Availability of FDA Publications Translated into various Languages

Food Lion Hard and Soft Taco Nutrition Label

 FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

 FierceBiotech
Addex axes 28 in wake of positive Parkinson's drug study

UC San Diego blueprints $110M R&D collaboration complex

Aveo on a hiring spree as it preps for the launch of tivozanib

Ono's oral MS drug eliminates brain lesions in promising Phase II study

Tech visionary Thiel sets out to spark a biotech revolution
FierceBiotech IT
Industry Voices: In Pursuit of Scientific Hive Mind

Pharma groups stand out in social media realm

Video gamers unravel drug discovery riddles

Takeda backs analysis of genomic data on brain diseases

Amazon hungers for genomics data after NIH pact

 FierceBiotech Research
German scientists generate nerve cells directly from skin/umbilical cells

Surging research in Asia is an opportunity for us

UCLA morphs stem cells into T-cell missiles that seek and destroy HIV

Injected protein clumps trigger Parkinson's progression in mice

Mayo team spies new class of breast cancer mutation

 FiercePharma
Forest profits reel as Lexapro faces first copycats

J&J pharma revenues tick upward on new products, overseas sales

How Amgen's CEO learned to listen--and why

Glaxo CFO opens a new playbook

Chinese regulators freeze sales of drugs with toxic capsules
FiercePharma Manufacturing
Manufacturing issues continue to undermine J&J earnings

Innovative construction project boosts Merck's Zostavax manufacturing

Penn Pharma expanding manufacturing in South Wales, U.K.

Innovative construction project boosts Merck's Zosavax manufacturing

South Africa creates list of drugs it will buy only if they are made there

 FierceVaccines
Biovest plans Canadian submission for personalized cancer vax

HIV vaccines: When is a failure actually a success

Vaccine approach could trick immune system

Asthma vaccine hopes rise in preclinical trials

'Universal' cancer vaccine not miraculous but could bring hope

 Health News - BizJournals.com
Hospitals spending more with firms owned by women, minorities

Priva Health lands $12.3M investment

Stellar completes building expansion and rennovation

Weinberg thinking long term on health care

Lumeris to open technology center in Austin

Health News - CNBC
Summary Box: J&J 1Q profit jumps despite sales dip

J&J 1Q profit jumps despite sales dip

Ventas buys 16 senior living communities for $362M

Trump on Taxes

Court says patent correction needed

 Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

 Inside Industry - Gen
With Acquisition of Bayer Imaging R&D Portfolio, Piramal Continues Shift to Pharma IP

Roche Reports Sales Dip in First Quarter of This Year

Shire to Purchase Substantially All Pervasis Assets to Fortify Regenerative Medicine Business

GEN Poll Majority Favors Moratorium on Synthetic Bio Products

VC Firm Flagship Ventures Joins a Merck Fund in Launching Biotech Startups
Marketwire - Pharma and Biotech
Derma Sciences, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference

Capital Group Holdings Announces Marketing Agreement Between OneHealthPass(TM) and Alliance Urgent Care, LLC

Novo Nordisk A/S : US Supreme Court Ruling Allows Caraco Pharmaceutical to Challenge Novo Nordisk's Patent Submissions for Prandin(R) (repaglinide)

Chembio Diagnostic Systems, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference

Sterilmed Sponsors US and European CleanMed Conferences for Health Care Sustainability

 MassBio News
New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

10 reasons to attend bio international convention

BioPharm America 2012

 Medical Pharma - PR Newswire
Texas Health Resources and Healthways Unveil New Model For Improving the Health of People and Communities

President John A. Kufuor Appointed Advocate for Neglected Tropical Disease Control

Profil Institute for Clinical Research to Continue Support of Insulindependence as Gold-Level Sponsor in 2012-2013

Hutchinson Center President Larry Corey Elected to American Academy of Art and Sciences 2012 Class of Fellows

Brenda Schulman, Ph.D., Recognized as 2012 Fellow of the American Academy of Arts and Sciences
National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

 Nature Biotechnology
Use of genome-wide association studies for drug repositioning

The art of the alliance

Addgene provides an open forum for plasmid sharing

Tensha Therapeutics

Positive signals from Washington

 New York Times- Biotechnology
Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

A Genome Deluge
New York Times- Pharmaceuticals
Justices Review Overtime Exemption for Drug Firm Representatives

6 Bronx Residents Charged in Prescription Drug Ring

Robber Killed After East Harlem Drugstore Holdup, Police Say

Managing Pain

Rite Aid Improved Sales in Fourth Quarter

 OnBioVC
1Q12 White Paper | A is for Innovation And

Promedior, Inc.: Series D $21.5M

Collegium Pharmaceutical, Inc.: Series B $22.5M

BioAmber, Inc.: Series C $30M

LanzaTech, Ltd.: $55.8M Series C

 Outsourcing-Pharma
Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Catalent eyes emerging market expansion of end-to-end development service model

Comparator sourcing is a complex challenge in a globalised market says Clinigen
Pharma News - Business Wire
Research and Markets: What Do Patients Think of Pharma's HIV/AIDS R&D Study Features 20 Pharma Companies and 32 Biotech Companies

Research and Markets: Brazil Retail Report Q2 2012 - Over-The-Counter (OTC) Pharmaceutical Sales to Increase from an Expected US$5.53bn in 2012 to US$8.85bn By 2016

BioAlliance Pharma: Full-Year Financial Results for 2011

Riassunto: Q-Med revoca l'indicazione di Macrolane per interventi di accrescimento del seno

New Image-Pro Premier Image Analysis Software Accelerates Life Science & Industry

 Pharma News - PharmiWeb
MassChallenge 2010 Competition Winner Awarded Research Grant

Statement by the Honourable Leona Aglukkaq, Minister of Health, on Tobacco Control

Health Canada - Note to editors - CARN Apr 2012

AOCS Releases Official Methods of Analysis for Total Fat and Fatty Acids in Foods

New Study of Leaders Reveals Emerging Global Talent Crisis, Emotional Intelligence Seen as Solution

 Pharma News - PR Newswire
Anthera Pharmaceuticals to Present at the BioCentury Future Leaders Conference

IQPC präsentiert Cold Chain IQ, das internationale Ressourcenzentrum für Temperaturüberwachungsprofis, in neuer Form

OrthoTec 2012 Keynote Speakers Announced

Kansas' Stop-Sale System Achieves Significant Quarterly Results In Battle Against Meth

Illinois' Stop-Sale System Achieves Significant Quarterly Results In Battle Against Meth
Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

 PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

 PRWeb - Biotechnology
Alpha Source, Inc. to Hold Third Annual Calumet Road Cleanup in Honor...

Wingu Announces Funding Led by Google Ventures: Software to Accelerate...

New Discovery could Speed Up Research Aimed at Solving ALS and Other...

Sanford-Burnham's Conrad Prebys Center for Chemical Genomics Using...

Kitware Awarded SBIR Funding to Improve DOE Knowledgebase System
PRWeb - Pharmaceuticals
Medication Discount Card Announces Partnership With Pioneering...

Trinity Consultants Expands and Relocates Iowa Office

Chain Drug Marketing Association Adds Dr. Neuzil's Irrigator to...

Healthcare Solutions and Broadspire Announce Development of an...

Care Communications, Inc. Announces the Promotion of Laurie Hebert to...

 Scientific American
Gene Hunt Is On for Mental Disabilities in Children

Hierarchy of Color Naming Matches the Limits of Our Vision System

Apes' Simple Nests Are Feats of Engineering

Memory Foraging: When the Brain Behaves Like a Bee

Penguins from Space: A New Satellite Census Doubles the Known Population of Emperors

 Sports - ESPN Basketball
Sources: SMU expecting decision from Brown

USBWA moves awards ceremony to Okla. City

Weatherspoon and Sibert leaving Ohio State

Weatherspoon says he's leaving Ohio State

Kentucky players to announce draft intentions
Sports News - ESPN
Penn St. AD, ex-VP seek delay in pretrial filings

Penn State prez subpoenaed in Sandusky trial

Bama's crystal BCS trophy shattered in mishap

South Florida DT Grissom has broken ankle

Paper that broke Penn St. scandal wins Pulitzer

 Xconomy Life Sciences
Five Questions: Acorda CEO Ron Cohen on the Future of Neurology R&D

Enzyme Maker Alcresta Nabs $10M from Third Rock, Bessemer, Frazier

Dendreon CEO John Johnson: This is My Last Stop

Abbott's Humira, the 3rd-in-Class Drug That Toppled Lipitor as No. 1

Pervasis, Flagship, SeventhSense, & More Boston Life Sciences Newsmakers

 Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)


SourceSolution © 2008-2012